Pharma Sector Overview for Q2-FY2009
Many of the top pharmaceutical companies are expected to report a healthy 23% increase in revenues for Q2-FY2009. It would mainly be driven by a steady growth in the domestic market, the new product launches in the regulated markets, a strong growth in the contract research and manufacturing services businesses and the consolidation of the acquisitions made in the previous year. With exports accounting for over 50% of the pharmaceutical industry’s revenues, the weaker rupee would also aid the top line …
